These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26551512)

  • 1. Looking Back at the 30th Nagoya International Cancer Treatment Symposium.
    Naoe T
    Oncology; 2015; 89 Suppl 1():IV. PubMed ID: 26551512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute Leukemia Forum '98. Advances and controversies in the biology and treatment of acute myelogenous leukemia and myelodysplasia. Symposium proceedings. San Francisco, California, USA. March 6, 1998.
    Leukemia; 1998 Sep; 12 Suppl 1():S1-56. PubMed ID: 9841272
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances and controversies in the biology and therapy of acute leukaemia and myelodysplasia.
    Rowe JM
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):475-8. PubMed ID: 19959095
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality].
    Calderón-Cabrera C; Falantes JF; Bernal R; Pérez-Simón JA
    Med Clin (Barc); 2015 Sep; 145(5):224-6. PubMed ID: 25190583
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
    Horiguchi H; Kobune M; Kikuchi S; Yoshida M; Murata M; Murase K; Iyama S; Takada K; Sato T; Ono K; Hashimoto A; Tatekoshi A; Kamihara Y; Kawano Y; Miyanishi K; Sawada N; Kato J
    Haematologica; 2016 Apr; 101(4):437-47. PubMed ID: 26802051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related myelodysplastic syndromes.
    Park DJ; Koeffler HP
    Semin Hematol; 1996 Jul; 33(3):256-73. PubMed ID: 8819235
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-related acute leukemia.
    Karp JE; Sarkodee-Adoo CB
    Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overview--disorders in bone marrow].
    Komatsu N
    Rinsho Ketsueki; 2012 Jan; 53(1):36-8. PubMed ID: 22374523
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
    Tefferi A
    Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelodysplastic syndromes (preleukemia).
    Koeffler HP
    Semin Hematol; 1986 Oct; 23(4):284-99. PubMed ID: 3535083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current treatment options for myelodysplastic syndromes].
    Nolte F; Hofmann WK
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1863-9. PubMed ID: 20842606
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
    Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
    Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Sill H; Zinke-Cerwenka W; Berghold A
    Bone Marrow Transplant; 2007 Apr; 39(8):509; author reply 509-10. PubMed ID: 17322936
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.
    Sandberg AA; Chen Z
    In Vivo; 1994; 8(5):807-18. PubMed ID: 7727729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in inpatient costs of hematopoietic cell transplantation among transplant centers in the United States.
    Thao V; Kozhimannil KB; Thomas W; Golberstein E
    JAMA Intern Med; 2014 Aug; 174(8):1409-12. PubMed ID: 24934623
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow transplantation in 614 patients: twenty year experience of the Nagoya Bone Marrow Transplantation Group (NBMTG).
    Hirabayashi N; Kodera Y; Matsuyama T; Tanimoto M; Horibe K; Naoe T; Kojima H; Yamada H; Utsumi M; Morishima Y
    Transplant Proc; 1995 Feb; 27(1):1380-2. PubMed ID: 7878920
    [No Abstract]   [Full Text] [Related]  

  • 20. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
    Nazha A; Sekeres MA
    Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.